Pharmacotherapy of children and adolescents with pervasive developmental disorders.
Hanft
Alan
A
University of California-Irvine, USA.
Hendren
Robert L
RL
D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000339:Affect / Q000187:drug effects; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001321:Autistic Disorder / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy*; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D017367:Selective Serotonin Reuptake Inhibitors